Myriad has changed a lot over the past 20 years. We’ve gone from being a single product company in just the United States to a company with 15 products on
the market or in development and operations around the world. We are transforming into a leader in the personalized medicine industry with our innovative,
high-quality molecular diagnostics. And today, for the first time since our founding, we’re updating our logo:

  • The new logo consists of elements that are true to the heritage of our company and our passion for patients.
  • The icon
    is a modernized helix that symbolizes our pioneering science and world-class expertise in DNA sequencing, RNA analysis and proteomics.
  • The tagline, “When Decisions Matter” reflects our commitment to being trusted advisors to patients and physicians earned by a relentless pursuit of perfection and
    professional integrity.

myriad-logo-unveiling

Click here to learn more about “When Decisions Matter” from Mark Capone, CEO of Myriad Genetics

Investor Day

August 11, 2022